Journal Search Engine
Search Advanced Search Adode Reader(link)
Download PDF Export Citaion korean bibliography PMC previewer
ISSN : 1229-6457(Print)
ISSN : 2466-040X(Online)
The Korean Journal of Vision Science Vol.21 No.2 pp.281-289
DOI : https://doi.org/10.17337/JMBI.2019.21.2.281

The Role of 4-hydroxynonenal for Activation of Vascular Smooth Muscle Cell

Ji-Young Lee*
Dept. of Ophthalmic Optics, Suseong College, Professor, Daegu

* Address reprint requests to Ji-Young Lee Dept. of Ophthalmic Optics, Suseong College, Professor, Daegu TEL: +82-53-749-7267, E-mail: jylee@sc.ac.kr
November 5, 2018 June 18, 2019 June 24, 2019

Abstract

Purpose :

Retinal diseases (RD), including proliferative diabetic retinopathy, are among the most important eye diseases leading to vision loss in industrialized countries. In this review, the importance of 4-hydroxynonal (HNE) in association with vascular smooth muscle cell (VSMC) activation leading to vascular remodeling, especially for oxidative stress- related retinal degeneration, is illustrated.


Methods :

RD is characterized by abnormal angiogenesis associated with an increase in cell proliferation and apoptosis. Angiogenesis in proliferative diabetic retinopathy is a complex multistep phenomenon consisting of the sprouting and the growth of new capillary blood vessels starting from the preexisting ones. Therefore, we investigated the action of HNE in VSMC activation causing vascular remodeling. The important role of HNE as a mediator of oxidative stress-related activation of VSMCs will be also discussed.


Results :

HNE increased the nitro oxide generation in VSMC. HNE seems to cause cellular structural perturbations and various oxidative stress-related degenerative processes, including vascular dysfunction. HNE also, increased the protein kinase B (Akt) phosphorylation. Oxidative stress by HNE could be mediated an induction of Akt phosphorylation and cell proliferation.


Conclusion :

Oxidative stress induced by HNE may play a critical role in the pathogenesis of retinal atherosclerosis and vascular disturbance, as angiogenesis. The apparent ability of HNE for activation of VSMC may significantly contribution the promotion and progression of vascular remodeling in oxidative-stress related retinal degeneration.



혈관평활근세포의 활성화에 대한 4-hydroxynonenal의 역할

이 지영*
수성대학교 안경광학과, 교수, 대구

    Ⅰ. Introduction

    Many researchers working on oxidative stress, followed by Esterbauer et al.1) who defined the role of 4-hydroxynonenal (HNE), would agree that NHE is a toxic product of lipid peroxidation and second messenger of free radicals. Peroxidative degradation of lipids produces the oxidized low-density lipoprotein (LDL) or the bioactive aldehyde HNE that are intimately involved in the pathogenesis of cardiovascular diseases like atherosclerosis2,3) because of its consistent detection in atherosclerotic lesion4,5) and fibrotic plaque in humans.6) The formation of atherosclerotic lesions is a complex process that is primarily mediated by inflammatory and oxidative process with its accompanying vascular dysfunction including smooth muscle cell (VSMC).7)

    Oxidative stress is one of the factors that can promote both VSMC proliferation/migration in atherosclerotic lesions and VSMC apoptosis, which is potentially involved in atherosclerotic plaque instability and rupture.8,9) In contrast to the stable atherosclerotic plaque according to VSMC proliferation, the unstable variety may become enlarged and lead to plaque rupture and thrombosis.10) Unstable plaque is characterized by the presence of a sustained inflammatory stimulus, which in turn is maintained by sustained partial cell death.11,12) HNE consistently presents in significant amounts in unstable atherosclerotic plaque, and most likely provides a primary contribution to the whole process through their pronounced proinflammatory, profibrogenic and proapoptotic effects.13,14) It requires the cooperation of several cell types such as endothelial cells(ECs), VSMCs, which should be activated, proliferate and migrate to invade the extracellular matrix and cause vascular remodeling.15,16)

    Thus, the apparent ability of HNE to favour the activation of VSMC points to a probably significant contribution to the promotion and progression of atherosclerosis. In this review, we will examine the current evidence of linking reactive aldehyde, HNE, to VSMC activation leading to oxidative stress-related retinal degeneration and vision loss.

    Ⅱ. Biochemical action of HNE

    Major sources of reactive aldehydes in vivo are lipid peroxidation, glycation, and acid oxidation.17) Lipid peroxidation proceeds by a free radical chain reaction.1) Termination of lipid peroxidation occurs when two radical species react with each other to form a non-radical product.18) Overall, lipid peroxidation is a self-propagating process that will proceed until a substrate is consumed or termination occurs.

    There are broad outcomes to lipid peroxidation, structural damage to membranes and generation of bioactive secondary products fragmentation of lipid hydroperoxides. In addition, lipid peroxidation produces abnormal fatty acid esters and liberates a number of diffusible products, some of which are potent electrophiles.19) Chemical reactive aldehydes, such as malondialdehyde(MDA), acrolein, NHE, and 4-hydroxylhexenal(HHE) is known as the most abundant products of lipid peroxidation.1) Among these reactive aldehydes, HNE quantitatively represents a major aldehydic product of the nonenzymatic oxidative breakdown of polyunsaturated fatty acids (FUFAs), namely linoleic and arachidonic acids.1,20)

    HNE contains three functional groups making it highly reactive: a C=C double bond, a carbonyl group, and a hydroxyl group. HNE can react with the thiol and amino groups of macromolecules including proteins, peptides, lipids, and nucleic acids.20,21) Primary reactants for HNE are the amino acids cysteine, histidine and lysine22-24) to crosslink proteins via reaction of the adduct aldehyde with amines. The mechanism of modification of these amino acids with HNE that it primarily forms adducts having a hemiacetal structure via the Michael reaction.17) As a strong electrophile, HNE can also significantly alter cellular redox status by depleting cellular sulfhydryl compounds, such as glutathione (GSH).22,23)

    As noted in a review,11,25) HNE-protein adducts have been detected in a variety of animal models of oxidative stress, as well as in tissues prepared from humans having clinically divers diseases associated with oxidative stress linked directly or indirectly with chronic inflammation. However, the action mechanism of HNE-modified protein in the cellular damage accompanying oxidative stress is not well described.

    Ⅲ. HNE as a mediator of oxidative stress in vasculature

    In human venous plasma, normal HNE levels were estimated between 0.3-1.0 μM.18) However, under pathological conditions, concentrations of HNE can be markedly enhanced and accumulated at concentrations up to 5 mM in response to oxidative insult.1,19,24) HNE have been shown to induce intracellular oxygen species (ROS) production in cultured VSMC.16) Moreover, HNE can produce the nitro oxide (NO) in VSMC (Fig. 1). HNE are also known to cause cellular structural perturbations and various redox-related degenerative processes, including vascular dysfunction.26) NO seems to be cause diabetic angiopathy.27,28)

    Previous studies demonstrated molecular course by which, in endothelial cells, oxidative stressmediated the nuclear factor-κB (NF-κB) activation mechanism was elicited, especially by reactive aldehydes (Fig. 2). It seems that HNE mediating redox disturbances and/or oxidative stress are intricately involved in vascular dysfunction.24,26,29)

    Compared to free radicals, the aldehydes are biologically active compounds, and it is known as long-lived and diffusible compounds. Aldehydes also have a capacity to attacking macromolecules distant from the initial oxidative event.1) Aldehydes, HNE and HHE may have no cell surface receptors but directly react with matrix tissue or cell surface proteins which may resulted in causing alteration of the structure and function of matrix proteins.

    Ⅳ. HNE as signaling molecule occurring proinflammatory process

    During progression of atherosclerosis, inflammation certainly plays a pivotal role.30,31) Although the initial phase of atherogenesis involves endothelial activation and immune cell recruitment, the evolution of this lesion is critically modulated by VSMCs. Through effects on VSMC migration, proliferation, and elaboration of cytokines, proinflammatory stimuli can alter atherosclerotic lesion characteristics and attendant complication.11,12) Validation of VSMC response to proinflammatory stimuli is, thus, of considerable interest.

    Aldehydes can cause redox disturbances and various degenerative processes. The redox sensitive transcription factor NF-κB has an important function in the regulation of many genes involved in the inflammatory and proliferative responses of cells and apoptotic cell death. Recent studies indicate that NF-κB is involved not only in pathogenesis of atherosclerosis.32,33) Our data definitely proved the ability of HHE to activation of NF-κ B, which can lead to vascular dysfunction by the activation of various proinflammatory genes such as nitric oxide synthase (iNOS).34) iNOS is reported to be found in a number of different cell types in the vessel wall, including VSMCs after arterial balloon injury or exposure to inflammatory cytokines, such as interleukin-1β, tumor necrosis factor, and γ-interferon.35-37)

    Our other report provides new insights into the molecular events of HHE-induced vascular dysfunction and the insidious vascular inflammatory process that NF-κB activation through inhibitory-κB kinase/ NF-κB-inducing kinase (IKK/NIK) pathway and/or p38 Mitogen-activated protein kinase (p38 MAPK) and extracellular signal-regulated kinase (ERK) activation.38) Therefore, it is suggested that upregulation of NF-κB-regulated gene expression by reactive aldehydes contributes at certain stages of atherosclerosis to chronic inflammation finally leading to retinal degeneration (Fig. 2). Previous studies underlay molecular course by which oxidative stress-mediated the NF-κB activation mechanism elicited by reactive aldehydes. The mechanism might lead to vascular dysfunction by the activation of various proinflammatiry genes such as inducible iNOS, cyclooxygenase-2 (COX-2), and xanthine oxidase (XOD).34,38,39)

    Ⅴ. Dual effects of HNE on proliferation and apoptosis in VSMC

    VSMC proliferation and apoptosis are plays essential roles in vascular development and atherosclerosis.11-13) The proliferation and migration of VSMC from the media to the intima layer of the arterial wall represent one of the end stage events in atherogenesis as it contributes to the formation of fibrous cap over the atherosclerotic plaques.40) Death of VSMCs has been demonstrated in vessel development and in disease, most notably in atherosclerosis, but also after injury and remodeling.

    HNE has been widely accepted as an inducer and mediator of oxidative stress of events leading to pathogenesis like atherosclerosis involved VSMC proliferation and apoptosis.13,36) Excess oxidative stress may be toxic, exerting cytostatic effects, causing membrane damage, and activating pathways of cell death (apoptosis and/or necrosis). According to the previous study, HNE and HHE induce the cell apoptosis associated with oxidative stress in vascular cells.13,26) Produced HNE with relatively large amounts is believed to be responsible for the key mediator of oxidative stress-induced cell death.

    However, recent studies show that HNE/HHE under nontoxic levels can stimulate the expression of early growth-response genes in some cell type. This study found that HNE, at low levels, induced the Akt phosphorylation (Fig. 3). It may act via attenuating apoptosis and increasing synthesis of NO through both the phosphatidylinositol 3-kinase (PI3K)/Akt and MAPK signaling pathway to reduce oxidative stress and cell apoptosis.41) While oxidative stress mediated induction of Akt phosphorylation and cell proliferation are known,42,43) it appears that kinases play an important role on downstreaming of the oxidative stress, which is integrating ROS signals into general cellular responses.44,45) This study indicates an oxidative stress in VSMCs subjected to vascular dysfunction where HNE could mediate these effects influencing the cellular signals upstream of Akt phosphorylation. Even the hyperproliferation of VSMCs that occurs in vascular disease may, at least in part, be mediated by HNE.

    Ⅵ. Conclusions

    Taking all available data together, it is seems reasonable to consider HNE as one of the molecules consistently involved in the vascular disorder leading to oxidative stress-related retinal degeneration and vision loss, both in the formation of the atheroma and in the fibrotic transformation of the arterial wall. HNE induced by oxidative stress involved in the initiation of the atherosclerotic lesion through the VSMC activation.

    Figure

    JMBI-21-2-281_F1.gif

    HNE-induced NO generation in VSMC. The graphs are representatives of NO production by HNE. The cells were incubated with 20 mM HNE for 5 min and loaded with DAF-2. FL-1, the fluorescence height of DAF-2 of VSMC. The fluorescence intensity analyzed using by FACS.

    JMBI-21-2-281_F2.gif

    Schematic presentation of reactive aldehydes on NF-κB activation in molecular inflammation involved vascular disorder. Reactive aldehyde induces the NF-κB transactivation by activating p38 MAP kinase and ERK and dependent on IKK resulting in up-regulation of the proinflammatory genes which lead to vascular dysfunction. ERK; extracellular regulated kinase. IKK; inhibitor kappa B kinase.

    JMBI-21-2-281_F3.gif

    Induction of the Akt phoshporylation by HNE in VSMC. The cells were incubated in serum free media with 1 mM HNE for 5-60 min. The amount of phosphorylated Akt protein was determined by Western blot analysis. The blots were first probed with the phospho-Akt antibodies. Thereafter, the same blot was reprobed with a monoclonal Akt antibody against total Akt protein.

    Table

    Reference

    1. Esterbauer H, Schaur RJ et al.: Chemistry and biochemistry of 4-hydroxynenenal, malonaldehyde and related aldehydes. Free Radic Biol Med. 11(1), 81-128, 1991.
    2. Rodriguez-Martinez MA, Alonso MJ et al.: Role of lipid peroxidation and the glutathionedependent antioxidant system in the impairment of endothelium-dependent relaxations with age. Br J Pharmacol. 123(1), 113-121, 1998.
    3. Uchida K, Toyokuni S at al.: Michael additiontype 4-hydroxy-2-nonenal adducts in modified low-density lipoproteins: markers for atherosclerosis. Biochemistry 33(41), 12487-12494, 1994.
    4. Wang X, Chen Q et al.: Modified lipoproteins in atherosclerotic lesions of human aorta. Zhonghua Bing Li Xue Za Zhi 27(1), 6-9, 1998. https://www.ncbi.nlm.nih.gov/pubmed/11244945
    5. Salonen JT: Epidemiological studies on antioxidants, lipid peroxidation and atherosclerosis. Arch Toxicol Suppl. 20, 249-267, 1998. https://www.ncbi.nlm.nih.gov/pubmed/9442298
    6. Leonarduzzi G, Chiarpotto E et al.: 4- Hydroxynonenal and cholesterol oxidation products in atherosclerosis. Mol Nutr Food Res. 49(11), 1044-1049, 2005.
    7. Fernández-Hernando C, József L et al.: Absence of Akt1 reduces vascular smooth muscle cell migration and survival and induces features of plaque vulnerability and cardiac dysfunction during atherosclerosis. Arterioscler Thromb Vasc Biol. 29(12), 2033-2040, 2009.
    8. Leonarduzzi G, Scavazza A et al.: The lipid peroxidation end product 4-hydroxy-2,3-nonenal up-regulates transforming growth factor beta1 expression in the macrophage lineage: a link between oxidative injury and fibrosclerosis. FASEB J. 11(11), 851-857, 1997.
    9. Uchida K: Role of reactive aldehyde in cardiovascular diseases. Free Radic Biol Med. 28(12), 1685-1696, 2000. DOI:https://www.ncbi.nlm.nih.gov/pubmed/10946210
    10. Strohmaier H, Hinghofer-Szalkay H et al.: Detection of 4-hydroxynonenal (HNE) as a physiological component in human plasma. J Lipid Mediat Cell Signal 11(1), 51-61, 1995. DOI:https://www.ncbi.nlm.nih.gov/pubmed/7728417
    11. Dzau VJ, Braun-Dullaeus RC et al.: Vascular proliferation and atherosclerosis: new perspectives and therapeutic strategies. Nat Med. 8(11), 1249-1256, 2002.
    12. Bennett M, Yu H et al.: Signalling from dead cells drives inflammation and vessel remodeling. Vascul Pharmacol. 56(5-6), 187-192, 2012.
    13. Lee JY, Jung GY et al.: 4-Hydroxynonenal induces vascular smooth muscle cell apoptosis through mitochondrial generation of reactive oxygen species. Toxicol Lett. 166(3), 212-221, 2006.
    14. Kang DY, Lee JY et al.: 4-Hydroxynonenal Induces Endothelial Apoptosis through Mitochondrial Depolarization. J Life Sci. 18(11), 1513-1520, 2008.
    15. Wang L, Bao H et al.: Secreted miR-27a Induced by Cyclic Stretch Modulates the Proliferation of Endothelial Cells in Hypertension via GRK6. Sci Rep. 20(7), 41058, 2017.
    16. Orlova VV, Drabsch Y et al.: Functionality of endothelial cells and pericytes from human pluripotent stem cells demonstrated in cultured vascular plexus and zebrafish xenografts. Arterioscler Thromb Vasc Biol. 34(1), 177-186, 2014.
    17. Satoh K, Nigro P et al.: Oxidative stress and vascular smooth muscle cell growth: a mechanistic linkage by cyclophilin A. Antioxid Redox Signal 12(5), 675-682, 2010.
    18. Plutzky J: Atherosclerotic plaque rupture: emerging insights and opportunities. Am J Cardiol. 84(1A), 15J-20J, 1999.
    19. Uchida K: 4-hydroxy-2-nonenal: a product and mediator of oxidative stress. Prog Lipid Res. 42(4), 318-343, 2003. https://www.ncbi.nlm.nih.gov/pubmed/12689622
    20. Poli G, Albano E et al.: The role of lipid peroxidation in liver damage. Chem Phys Lipids. 45(2-4), 117-142, 1987. https://www.ncbi.nlm.nih.gov/pubmed/3319224
    21. Schaur RJ: Basic aspects of the biochemical reactivity of 4-hydroxynonenal. Mol Aspect Med. 24(4-5), 149-159, 2003.
    22. Fukuda A, Osawa T et al.: 4-Hydroxy-2- nonenal cytotoxicity in renal proximal tubular cells: protein modification and redox alteration. Arch Biochem Biophys. 333(2), 419-426, 1996.
    23. Haberland A, Schütz AK et al.: The influence of lipid peroxidation products (malondialdehyde, 4-hydroxynonenal) on xanthine oxidoreductase prepared from rat liver. Biochem Pharmacol. 43(10), 2117-2120, 1992. https://www.ncbi.nlm.nih.gov/pubmed/1599498
    24. Uchida K, Stadtman ER: Modification of histidine residues in proteins by reaction with 4-hydroxynonenal. Proc Natl Acad Sci USA. 89(10), 4544-4548, 1992.
    25. Lee JY: Importance oxidative stress in ocular dysfunction. J Korean Ophthalmol Soc. 13(3), 103-109, 2008. http://jkoos.or.kr/?___M_ID=143
    26. Lee JY, Je JH et al.: Induction of endothelial apoptosis by 4-hydroxyhexenal. Eur J Biochem. 271(7), 1339-1347, 2004.
    27. Santilli F, Cipollobe F et al.: The role of nitric oxide in the development of diabetic angiopathy. Horm Metab Res. 36(5), 319-335, 2004
    28. Lee JY, Park JY et al.: The role of Janus kinase in superoxide-mediated proliferation of diabetic vascular smooth muscle cells. Korean J Physiol Pharmacol. 11(1), 31-36, 2007. http://www.koreascience.kr/article/JAKO200712242536414.page
    29. Mattson MP: Roles of the lipid peroxidation product 4-hydroxynonenal in obesity, the metabolic syndrome, and associated vascular and neurodegenerative disorders. Exp Gerontol. 44(10), 625-633, 2009.
    30. Libby P: Inflammation in atherosclerosis. Arterioscler Thromb Vasc Biol. 32(9), 2045-2051, 2012.
    31. Libby P: Inflammation in atherosclerosis. Nature. 420(6917), 868-874, 2002.
    32. Sun X, Feinberg MW: NF-κB and hypoxia: a double-edged sword in atherosclerosis. Am J Pathol. 181(5), 1513-1517, 2012.
    33. Van-Assche T, Huygelen V et al.: Gene therapy targeting inflammation in atherosclerosis. Curr Pharm Des. 17(37), 4210-4223, 2011.
    34. Lee JY, Je JH et al.: Induction of endothelial iNOS by 4-hydroxyhexenal through NF-kappaB activation. Free Radic Biol Med. 37(4), 539-548, 2004.
    35. Qin ZX, Yu P et al.: Hydrogen-rich saline prevents neointima formation after carotid balloon injury by suppressing ROS and the TNF-α/NF-κB pathway. Atherosclerosis 220(2), 343-350, 2012.
    36. Lin SJ, Yang TH: Effects of Ginkgo biloba extract on the proliferation of vascular smooth muscle cells in vitro and on intimal thickening and interleukin-1beta expression after balloon injury in cholesterol-fed rabbits in vivo. J Cell Biochem. 85(3), 572-582, 2002.
    37. Berglund LM, Kotova O et al.: NFAT regulates the expression of AIF-1 and IRT-1: yin and yang splice variants of neointima formation and atherosclerosis. Cardiovasc Res. 93(3), 414-423, 2012.
    38. Je JH, Lee JY et al.: NF-kappaB activation mechanism of 4-hydroxyhexenal via NIK/IKK and p38 MAPK pathway. FEBS Lett. 566(1-3), 183-189, 2004.
    39. Lee JY, Yu BP et al.: Activation mechanisms of endothelial NF-kappaB, IKK, and MAP kinase by tert-butyl hydroperoxide. Free Radic Res. 39(4), 399-409, 2005. https://www.ncbi.nlm.nih.gov/pubmed/16028365
    40. Glass CK, Witztum JL: Atherosclerosis. The road ahead. Cell 104(4), 503-516, 2001. https://www.ncbi.nlm.nih.gov/pubmed/11239408
    41. Xiao X, Dong Y et al.: Adiponectin protects endothelial cells from the damages induced by the intermittent high level of glucose. Endocrine. 40(3), 386-393, 2011.
    42. Lahair MM, Howe CJ et al.: Molecular pathways leading to oxidative stress-induced phosphorylation of Akt. Antioxid Redox Signal. 8(9-10), 1749-1756, 2006.
    43. Yun MR, Lee JY et al.: Oleic acid enhances vascular smooth muscle cell proliferation via phosphatidylinositol 3-kinase/Akt signaling pathway. Pharmacilogical Res. 57(2), 97-102, 2006.
    44. Pasciu V, Posadino AM et al.: Akt downregulation by flavin oxidase-induced ROS generation mediates dose-dependent endothelial cell damage elicited by natural antioxidants. Toxicol Sci. 114(1), 101-112, 2010.
    45. Song YS, Narasimhan P et al.: The role of Akt signaling in oxidative stress mediates NF-kappaB activation in mild transient focal cerebral ischemia. J Cereb Blood Flow Metab. 28(12), 1917-1926, 2008.